Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumors.

Schrader KA, Gorbatcheva B, Senz J, Heravi-Moussavi A, Melnyk N, Salamanca C, Maines-Bandiera S, Cooke SL, Leung P, Brenton JD, Gilks CB, Monahan J, Huntsman DG.

PLoS One. 2009 Nov 24;4(11):e7988. doi: 10.1371/journal.pone.0007988.

2.

Functional exploration of the adult ovarian granulosa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G).

Benayoun BA, Caburet S, Dipietromaria A, Georges A, D'Haene B, Pandaranayaka PJ, L'Hôte D, Todeschini AL, Krishnaswamy S, Fellous M, De Baere E, Veitia RA.

PLoS One. 2010 Jan 20;5(1):e8789. doi: 10.1371/journal.pone.0008789.

3.

Mutational analysis (c.402C>G) of the FOXL2 gene and immunohistochemical expression of the FOXL2 protein in testicular adult type granulosa cell tumors and incompletely differentiated sex cord stromal tumors.

Hes O, Vaněček T, Petersson F, Grossmann P, Hora M, Perez Montiel DM, Steiner P, Dvořák M, Michal M.

Appl Immunohistochem Mol Morphol. 2011 Jul;19(4):347-51. doi: 10.1097/PAI.0b013e3182039ef2.

PMID:
21293260
4.

Mutation of FOXL2 in granulosa-cell tumors of the ovary.

Shah SP, Köbel M, Senz J, Morin RD, Clarke BA, Wiegand KC, Leung G, Zayed A, Mehl E, Kalloger SE, Sun M, Giuliany R, Yorida E, Jones S, Varhol R, Swenerton KD, Miller D, Clement PB, Crane C, Madore J, Provencher D, Leung P, DeFazio A, Khattra J, Turashvili G, Zhao Y, Zeng T, Glover JN, Vanderhyden B, Zhao C, Parkinson CA, Jimenez-Linan M, Bowtell DD, Mes-Masson AM, Brenton JD, Aparicio SA, Boyd N, Hirst M, Gilks CB, Marra M, Huntsman DG.

N Engl J Med. 2009 Jun 25;360(26):2719-29. doi: 10.1056/NEJMoa0902542. Epub 2009 Jun 10.

5.
6.

The FOXL2 mutation (c.402C>G) in adult-type ovarian granulosa cell tumors of three Japanese patients: clinical report and review of the literature.

Takahashi A, Kimura F, Yamanaka A, Takebayashi A, Kita N, Takahashi K, Murakami T.

Tohoku J Exp Med. 2013;231(4):243-50. Review.

7.

Absence of a FOXL2 mutation (402C→G) in the blood of adult-type granulosa cell tumor patients possessing the FOXL2 mutation.

Lee S, Kim TH, Won M, Ko JJ, Rho J, Lee K, Bae J.

Int J Gynecol Cancer. 2010 Nov;20(8):1341-3. doi: 10.1111/IGC.0b013e3181ff3e73.

PMID:
21051974
8.

The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary.

Jamieson S, Butzow R, Andersson N, Alexiadis M, Unkila-Kallio L, Heikinheimo M, Fuller PJ, Anttonen M.

Mod Pathol. 2010 Nov;23(11):1477-85. doi: 10.1038/modpathol.2010.145. Epub 2010 Aug 6.

9.

Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W).

Kim JH, Yoon S, Park M, Park HO, Ko JJ, Lee K, Bae J.

Oncogene. 2011 Apr 7;30(14):1653-63. doi: 10.1038/onc.2010.541. Epub 2010 Nov 29.

PMID:
21119601
10.

Aromatase is a direct target of FOXL2: C134W in granulosa cell tumors via a single highly conserved binding site in the ovarian specific promoter.

Fleming NI, Knower KC, Lazarus KA, Fuller PJ, Simpson ER, Clyne CD.

PLoS One. 2010 Dec 20;5(12):e14389. doi: 10.1371/journal.pone.0014389.

11.

Adult-type granulosa cell tumors and FOXL2 mutation.

Köbel M, Gilks CB, Huntsman DG.

Cancer Res. 2009 Dec 15;69(24):9160-2. doi: 10.1158/0008-5472.CAN-09-2669. Epub . Review.

12.

The transcriptional targets of mutant FOXL2 in granulosa cell tumours.

Rosario R, Araki H, Print CG, Shelling AN.

PLoS One. 2012;7(9):e46270. doi: 10.1371/journal.pone.0046270. Epub 2012 Sep 28.

13.

FOXL2 mutations in granulosa cell tumors occurring in males.

Lima JF, Jin L, de Araujo AR, Erikson-Johnson MR, Oliveira AM, Sebo TJ, Keeney GL, Medeiros F.

Arch Pathol Lab Med. 2012 Jul;136(7):825-8. doi: 10.5858/arpa.2011-0355-OA.

PMID:
22742556
14.

Identification and Validation of Differential Phosphorylation Sites of the Nuclear FOXL2 Protein as Potential Novel Biomarkers for Adult-Type Granulosa Cell Tumors.

Suh DS, Oh HK, Kim JH, Park S, Shin E, Lee K, Kim YH, Bae J.

J Proteome Res. 2015 Jun 5;14(6):2446-56. doi: 10.1021/pr501230b. Epub 2015 Apr 28.

PMID:
25871347
15.

Ovarian cellular fibromas lack FOXL2 mutations: a useful diagnostic adjunct in the distinction from diffuse adult granulosa cell tumor.

McCluggage WG, Singh N, Kommoss S, Huntsman DG, Gilks CB.

Am J Surg Pathol. 2013 Sep;37(9):1450-5. doi: 10.1097/PAS.0b013e31828e4f55.

PMID:
23774170
16.

FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines.

Kommoss S, Anglesio MS, Mackenzie R, Yang W, Senz J, Ho J, Bell L, Lee S, Lorette J, Huntsman DG, Blake Gilks C.

Mod Pathol. 2013 Jun;26(6):860-7. doi: 10.1038/modpathol.2012.226. Epub 2013 Jan 25.

17.

Mutational analysis of FOXL2 codon 134 in granulosa cell tumour of ovary and other human cancers.

Kim MS, Hur SY, Yoo NJ, Lee SH.

J Pathol. 2010 Jun;221(2):147-52. doi: 10.1002/path.2688.

PMID:
20198651
18.

Mutational analysis of FOXL2 p.C134W and expression of bone morphogenetic protein 2 in Japanese patients with granulosa cell tumor of ovary.

Oseto K, Suzumori N, Nishikawa R, Nishikawa H, Arakawa A, Ozaki Y, Asai H, Kawai M, Mizuno K, Takahashi S, Shirai T, Yamada-Namikawa C, Nakanishi M, Kajiyama H, Kikkawa F, Sugiura-Ogasawara M.

J Obstet Gynaecol Res. 2014 May;40(5):1197-204. doi: 10.1111/jog.12324. Epub 2014 Apr 2.

PMID:
24689977
19.

FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary.

Al-Agha OM, Huwait HF, Chow C, Yang W, Senz J, Kalloger SE, Huntsman DG, Young RH, Gilks CB.

Am J Surg Pathol. 2011 Apr;35(4):484-94. doi: 10.1097/PAS.0b013e31820a406c.

PMID:
21378549
20.

Molecular pathogenesis in granulosa cell tumor is not only due to somatic FOXL2 mutation.

Wang WC, Lai YC.

J Ovarian Res. 2014 Sep 6;7:88. doi: 10.1186/s13048-014-0088-0.

Items per page

Supplemental Content

Write to the Help Desk